{
  "trial_id": "NCT04697043",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "Primary confirmed distant metastatic breast cancer (M1)",
      "label": "met",
      "evidence": "A histologically proven diagnosis"
    },
    {
      "criterion": "of the breast tumor; A known hormonal and HER2Neu status;",
      "label": "unknown",
      "evidence": ""
    },
    {
      "criterion": "Having TNM classification: T1-T3, resectable T4 status, and N0-N3;",
      "label": "met",
      "evidence": ""
    },
    {
      "criterion": "performance status and comorbidity should allow surgery and/or systemic therapy;",
      "label": "unknown",
      "evidence": ""
    },
    {
      "criterion": "Accepting the surgery by written informed consent.",
      "label": "met",
      "evidence": ""
    }
  ],
  "exclusion": [
    {
      "criterion": "primary invasive breast cancer in the medical history;",
      "label": "not_met",
      "evidence": ""
    },
    {
      "criterion": "another malignancy within the last 10 years, besides basal cell carcinoma of the skin or early-stage cervical cancer;",
      "label": "unknown",
      "evidence": ""
    },
    {
      "criterion": "surgical treatment and/or radiotherapy of the breast tumor before randomization;",
      "label": "not_met",
      "evidence": ""
    }
  ],
  "notes": "Patient has distant metastatic breast cancer, HER2-positive, and ER/PR negative. She is in good performance status and comorbidity allows surgery and systemic therapy.",
  "_meta": {
    "topic_id": "25",
    "trial_id": "NCT04697043",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}